Safeguard Scientifics, Inc. (SFES)
USD 0.95
(11.71%)
USD 0.95
(11.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.3 Million | -3.25 Million | -8.15 Million | -8.14 Million | -19.97 Million | -26.03 Million |
| Net Income | -9.82 Million | -14.26 Million | 27 Million | -37.61 Million | 54.56 Million | -15.62 Million |
| Depreciation & Amortization | 319 Thousand | 271 Thousand | 229 Thousand | 311 Thousand | 1.06 Million | 692 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.12 Million | 1.44 Million | 1.77 Million | 965 Thousand | - | - |
| Change in working capital | 32 Thousand | -908 Thousand | -3.28 Million | -214 Thousand | -4.16 Million | -2.08 Million |
| Other non-cash items | 6.8 Million | 12.18 Million | -31.64 Million | 29.99 Million | -65.94 Million | -5.56 Million |
| Investing Cash Flow | 5.72 Million | -4.66 Million | 58.11 Million | -1.26 Million | 126.3 Million | 32.1 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | -149 Thousand | 6.87 Million | 60.83 Million | 369 Thousand | - | 1000.00 |
| Investment purchases | -11.78 Million | -17.54 Million | -2.71 Million | -9.17 Million | -73.93 Million | -54.16 Million |
| Sales/Maturities of investments | 14.65 Million | 6 Million | - | - | 95.93 Million | 18.87 Million |
| Other Investing Activities | 2.85 Million | 6.87 Million | 60.83 Million | 7.9 Million | 104.3 Million | 67.38 Million |
| Financing Cash Flow | -6.25 Million | -3.48 Million | -40.79 Million | -40 Thousand | -89.48 Million | -24.95 Million |
| Debt repayment | - | - | - | - | -68.56 Million | -24.68 Million |
| Dividends payments | -5.81 Million | - | - | - | -20.67 Million | - |
| Common Stock Repurchased | -75 Thousand | -2.93 Million | -40.65 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -358 Thousand | -549 Thousand | -144 Thousand | -40 Thousand | -236 Thousand | -267 Thousand |
| Accounts receivables | - | - | - | - | - | -2.06 Million |
| Accounts payables | 178 Thousand | -374 Thousand | -3.04 Million | -77 Thousand | -3.34 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 32 Thousand | -908 Thousand | -3.28 Million | -214 Thousand | -823 Thousand | -21 Thousand |
| Cash at beginning of period | 13.35 Million | 24.76 Million | 15.6 Million | 25.05 Million | 8.2 Million | 20.75 Million |
| Cash at end of period | 9.51 Million | 13.35 Million | 24.76 Million | 15.6 Million | 25.05 Million | 8.2 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -3.83 Million | -11.4 Million | 9.16 Million | -9.45 Million | 16.85 Million | -12.54 Million |
| Free Cash Flow | -3.3 Million | -3.25 Million | -8.15 Million | -8.14 Million | -19.97 Million | -26.03 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.7 Million | -2.01 Million | -4.41 Million | -9.82 Million | 932 Thousand | -2.86 Million |
| Depreciation & Amortization | - | - | 319 Thousand | 319 Thousand | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 1.12 Million | - | - |
| Change in working capital | - | - | - | 32 Thousand | - | - |
| Other non-cash items | 841 Thousand | 513 Thousand | 3.91 Million | 6.8 Million | -1.36 Million | 1.72 Million |
| Investing Cash Flow | 55 Thousand | - | 551 Thousand | 5.72 Million | 1.86 Million | 4.39 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 551 Thousand | -149 Thousand | 1.01 Million | -2.56 Million |
| Investment purchases | - | - | - | -11.78 Million | - | -3.84 Million |
| Sales/Maturities of investments | - | - | -250 Thousand | 14.65 Million | 850 Thousand | 7.8 Million |
| Other Investing Activities | 55 Thousand | - | 551 Thousand | 2.85 Million | 1.01 Million | 437 Thousand |
| Financing Cash Flow | - | -9000.00 | -5.9 Million | -6.25 Million | -20 Thousand | -26 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -5.81 Million | -5.81 Million | - | - |
| Common Stock Repurchased | - | - | - | -75 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -9000.00 | -82 Thousand | -358 Thousand | -20 Thousand | -26 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | 178 Thousand | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | 32 Thousand | - | - |
| Cash at beginning of period | 8.01 Million | 9.51 Million | 15.68 Million | 13.35 Million | 14.27 Million | 11.03 Million |
| Cash at end of period | 7.2 Million | 8.01 Million | 9.51 Million | 9.51 Million | 15.68 Million | 14.27 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -805 Thousand | -1.5 Million | -6.16 Million | -3.83 Million | 1.41 Million | 3.23 Million |
| Free Cash Flow | -860 Thousand | -1.49 Million | -818 Thousand | -3.3 Million | -429 Thousand | -1.13 Million |
001500
600854
PYLON
GPRA
0374
VABK